| Literature DB >> 25409340 |
Xiaoyan Xu1, Yubang Shen1, Jianjun Fu1, Liqun Lu2, Jiale Li3.
Abstract
BACKGROUND: De novo transcriptome sequencing is a robust method of predicting miRNA target genes, especially for organisms without reference genomes. Differentially expressed miRNAs had been identified previously in kidney samples collected from susceptible and resistant grass carp (Ctenopharyngodon idella) affected by Aeromonas hydrophila. Target identification for these differentially expressed miRNAs poses a major challenge in this non-model organism.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25409340 PMCID: PMC4237362 DOI: 10.1371/journal.pone.0112722
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summaries of sequencing cDNA library.
| Sample name | SG | RG |
| Total reads | 73,063,654 | 62,737,669 |
| Clean reads | 70,210,307 | 60,668,815 |
| Total mapped to unigenes readcounts | 61,396,052.97 | 51,785,549.97 |
| Reads length (bp) | 101 | |
| GC content (%) | 48.43 | 47.13 |
| Number of unigenes | 199,554 | |
| Total length of unigenes (bp) | 195,075,872 | |
| Mean length of unigenes (bp) | 977 | |
| N50 of unigenes (bp) | 2,117 | |
| Maximal length of unigenes (bp) | 27,185 | |
Figure 1Length distribution of assembled unigenes in the sequenced cDNA library.
Statistics of the annotation results for the C. idella unigenes.
| All | Nr | Nt | Pfam | KOG | Swiss-Prot | KO | GO | |
| Number of unigenes | 61373 | 28311 | 46653 | 33013 | 16980 | 22674 | 27775 | 34207 |
| % of unigenes | 100 | 46.1 | 76.0 | 53.8 | 27.7 | 36.9 | 45.3 | 55.7 |
Nr: NCBI non-redundant protein sequences, Nt: NCBI non-redundant nucleotide sequences, Pfam: Protein family, KOG: Clusters of Orthologous Groups of proteins, Swiss-Prot: A manually annotated and reviewed protein sequence database, KO: KEGG Ortholog database and GO: Gene Ontology.
Figure 2Functional annotations of the unigenes of C. idella.
(A) KOG annotation. (B) Level 2 GO term distribution for the biological process, cellular component and molecular function categories.
Top 10 list of the gene number of Pathway Hierarchy 2.
| Pathway Hierarchy 2 | Unigene Number |
| Infectious Diseases | 3210 |
| Signal Transduction | 2316 |
| Cancers | 2235 |
| Nervous System | 1648 |
| Immune System | 1554 |
| Neurodegenerative Diseases | 932 |
| Digestive System | 875 |
| Endocrine System | 861 |
| Cell Communication | 859 |
| Signaling Molecules and Interaction | 763 |
Top 10 list of pathways related to immune system.
| Pathway Hierarchy 2 | KEGG Pathway | Unigene Numbers |
| Immune System | Chemokine signaling pathway | 224 |
| Immune System | Leukocyte transendothelial migration | 199 |
| Immune System | T cell receptor signaling pathway | 156 |
| Immune System | Fc gamma R-mediated phagocytosis | 155 |
| Immune System | Natural killer cell mediated cytotoxicity | 129 |
| Immune System | B cell receptor signaling pathway | 110 |
| Immune System | Toll-like receptor signaling pathway | 110 |
| Immune System | Antigen processing and presentation | 86 |
| Immune System | Fc epsilon RI signaling pathway | 84 |
| Immune System | RIG-I-like receptor signaling pathway | 67 |
Figure 3Number and Fold change distribution of differentially expressed genes between the SG/RG libraries.
Differentially expressed miRNAs in C. idella kidney between SG and RG.
| miRNA | Sequence (5′-3′) | SG (TMP) | RG (TMP) | log2 (Fold_change) normalized | p-value |
|
| UGAGGUAGUAGUUUGUGCUGUU | 3419.67473 | 1475.401006 | 1.212751983 | 4.62E-174 |
|
| UGUAGUGUUUCCUACUUUAUGGA | 4770.81118 | 9798.344345 | −1.038303405 | 0 |
|
| UAGCUUAUCAGACUGGUGUUGGC | 3431.54242 | 1640.502276 | 1.064719594 | 4.12E-142 |
|
| UACUGCAUCAGGAACUGAUUGG | 240.9140969 | 2983.647091 | −3.630486183 | 0 |
|
| UGUCAGUUUGUCAAAUACCCC | 1460.912578 | 6800.683353 | −2.218809871 | 0 |
|
| UGAAGGCCGAAGUGGAGA | 3.560306851 | 17.95531055 | −2.334337113 | 0.001253505 |
|
| UGCCCGCAUUCUCCACCA | 7.713998177 | 40.28996513 | −2.384869847 | 9.85E-07 |
|
| CCCAGCCAUAUUUGUUUGAAC | 16.02138083 | 0 | 4.768565529 | 4.44E-05 |
|
| UGUUUCUGGCUCUGAUAUUUGCU | 32.04276166 | 71.82124218 | −1.164412111 | 8.07E-05 |
26 pathways were related to immune and diseases in all pathways.
| KEGG Pathway | Pathway Hierarchy 2 | Target gene of different expression miRNA |
| Toll-like receptor signaling pathway | Immune system | JNK, TLR5, TBK1 |
| Hepatitis C | Infectious diseases: Viral | JNK, TBK1, LDLR |
| Salmonella infection | Infectious diseases: Bacterial | JNK, TLR5 |
| Fc epsilon RI signaling pathway | Immune system | JNK, FYN |
| Tuberculosis | Infectious diseases: Bacterial | JNK, PLK3, CTSS |
| Influenza A | Infectious diseases: Viral | JNK, DNAJB1, TBK1 |
| Measles | Infectious diseases: Viral | FYN, TBK1 |
| MAPK signaling pathway | Signal transduction | JNK, MKP |
| Toxoplasmosis | Infectious diseases: Parasitic | JNK, LDLR |
| Chemokine signaling pathway | Immune system | CCR7, ADCY7, DOCK2 |
| HTLV-I infection | Infectious diseases: Viral | JNK, ADCY7, SLC2A1 |
| Herpes simplex infection | Infectious diseases: Viral | JNK, TBK1 |
| Fc gamma R-mediated phagocytosis | Immune system | DOCK2 |
| Prion diseases | Neurodegenerative diseases | FYN |
| Viral myocarditis | Cardiovascular diseases | FYN |
| Pathways in cancer | Cancers: Overview | JNK, SLC2A1 |
| Transcriptional misregulation in cancer | Cancers: Overview | CCR7 |
| Type II diabetes mellitus | Endocrine and metabolic diseases | JNK |
| Cytokine-cytokine receptor interaction | Signaling molecules and interaction | CCR7, TNFSF12 |
| Antigen processing and presentation | Immune system | CTSS |
| Pertussis | Infectious diseases: Bacterial | JNK |
| Natural killer cell mediated cytotoxicity | Immune system | FYN |
| T cell receptor signaling pathway | Immune system | FYN |
| Chagas disease | Infectious diseases: Parasitic | JNK |
| Staphylococcus aureus infection | Infectious diseases: Bacterial | CFB |
| Complement and coagulation cascades | Immune system | CFB |
List of gene abbreviations: JNK: c-Jun N-terminal kinase, TLR5: toll-like receptor 5, TBK1: TANK-binding kinase 1, LDLR: low-density lipoprotein receptor, FYN: tyrosine-protein kinase Fyn, CTSS: cathepsin S, PLK3: polo-like kinase 3, DNAJB1: DnaJ homolog subfamily B member 1, MKP: dual specificity MAP kinase phosphatase, DOCK2: dedicator of cytokinesis protein 2, ADCY7: adenylate cyclase 7, SLC2A1: MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1, CCR7: C-C chemokine receptor type 7, TNFSF12: tumor necrosis factor ligand superfamily member 12, CFB: component factor B.
Figure 4The expression analysis of selected genes from the expression profile by relative quantitative real-time PCR.
A Transcriptome sequencing data, B Real-time PCR data. Increases and decreases in relative levels of transcripts with respect to the control 18s for mRNA and miR-22a for miRNA are shown. The settings “q.value <0.005” and “|log2.Fold change.normalized|>2” were used as thresholds for judging significant differences in transcript expression. One-way ANOVA tests were performed using SPSS 17.0 to determine significant differences for Real-time PCR data. Statistical significance of the relative expression ratio is indicated *.